Hepatic Steato-Fibrosis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Hepatic Steato-Fibrosis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06435611

Adiposity, Cardiometabolic and Neurocognitive Health Among Ethnic Groups: a Feasibility and Pilot Study

The goal of this pilot and feasibility study is to is to test the feasibility of conducting a cross-sectional study on adiposity and cardiometabolic and neuroco…

United Kingdom10 participantsStarted 2023-11-15

All recent trials (2 shown)

Not Yet RecruitingEarly Phase 1

NCT06373523

MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin

Non-alcoholic fatty liver disease (NAFLD) is a global epidemic with a prevalence of 25-40%.Primary Hypothyroidism is one of Endocrinopathies who are at risk of…

India60 participantsStarted 2024-09-01

Treatment: Dapagliflozin 10mg Tab, Placebo